Enanta Pharmaceuticals
ENTA
#7451
Rank
โ‚น37.85 B
Marketcap
โ‚น1,312
Share price
3.62%
Change (1 day)
93.60%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: โ‚น37.85 Billion

As of December 2025 Enanta Pharmaceuticals has a market cap of โ‚น37.85 Billion. This makes Enanta Pharmaceuticals the world's 7451th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น37.85 B246.44%
2024โ‚น10.92 B-33.76%
2023โ‚น16.49 B-79.39%
2022โ‚น80.06 B-29.85%
2021โ‚น114.13 B84.61%
2020โ‚น61.82 B-29.16%
2019โ‚น87.27 B-9.33%
2018โ‚น96.25 B34.32%
2017โ‚น71.66 B65.33%
2016โ‚น43.34 B5.1%
2015โ‚น41.24 B-31.25%
2014โ‚น59.98 B98.11%
2013โ‚น30.27 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Enanta Pharmaceuticals was reported to be:

โ‚น37.85 Billion
by Nasdaq info icon info icon
โ‚น37.85 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AbbVie
ABBV
โ‚น35.895 T 94,721.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น43.706 T 115,352.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น10.491 T 27,612.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น22.376 T 59,008.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น9.537 T 25,093.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น22.781 T 60,078.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland